LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

High Fat Diet Corrects Mitochondrial Dysfunction in Premature Aging Mouse Model

By LabMedica International staff writers
Posted on 12 Jul 2015
Image: In young but rapidly aging mice, high-fat diet feeding (right) ramps up heat production and metabolic activity relative to cooler mice fed a normal chow diet (left) (Photo courtesy of the Salk Institute).
Image: In young but rapidly aging mice, high-fat diet feeding (right) ramps up heat production and metabolic activity relative to cooler mice fed a normal chow diet (left) (Photo courtesy of the Salk Institute).
Metabolic disease researchers used a progeroid syndrome mouse model that exhibited symptoms of mitochondrial dysfunction to demonstrate the link between mitochondrial stress and the hormone FGF21 (fibroblast growth factor 21).

Progeroid means "resembling premature aging", and the progeroid POLG (polymerase gamma mtDNA mutator) mouse model was used by investigators at the Salk Institute (La Jolla, CA, USA) to study mitochondrial disease and premature aging.

These mice exhibited signs of metabolic imbalance including thermogenic defects in brown adipose tissue (BAT). A side effect of this adaptive response was the complete resistance to diet-induced obesity displayed by POLG mice when they were placed on a high-fat diet (HFD). Surprisingly, HFD further increased oxygen consumption in part by inducing thermogenesis and mitochondrial biogenesis in BAT along with enhanced expression of fibroblast growth factor 21 (FGF21).

FGF21 is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities and are involved in a variety of biological processes including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth, and invasion. Treatment of animals with FGF21 resulted in increased energy expenditure, fat utilization, and lipid excretion.

The investigators reported in the June 29, 2015, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) that the metabolic benefits induced by mild mitochondrial stress via FGF21 induction in POLG mice fed a high-fat diet enabled those mice to resist diet-induced obesity and its underlying associated disease states. In addition, nutrients from a HFD appeared to reverse metabolic imbalance in these mice. HFD also robustly increased fat metabolism and improved mitochondrial function in brown fat, which mediated adaptive thermogenesis.

"These findings help us understand the link between diet, health, and aging, and they give us the potential to dissect these connections in a molecular way that could lead to therapeutics," said senior author Dr. Ronald Evans, director of the gene expression laboratory at the Salk Institute. "What we believe now is that turning on FGF21 is an adaptation to help this animal maintain its metabolic health. If the mice did not have this hormonal "fountain of youth," they might age even more quickly than they already do."

Related Links:

Salk Institute


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Rapid Molecular Testing Device
FlashDetect Flash10

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more